Fibrocell and RDEB
Mar 9, 2018 ·
27m 49s
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
Jeanine Cook-Gerard from the Department of Nursing talks with John Maslowski, President and Chief Executive Officer of Fibrocell, about the rare genetic skin disease Recessive Dystrophic Epidermolysis Bullosa (RDEB). John...
show more
Jeanine Cook-Gerard from the Department of Nursing talks with John Maslowski, President and Chief Executive Officer of Fibrocell, about the rare genetic skin disease Recessive Dystrophic Epidermolysis Bullosa (RDEB). John describes Fibrocell’s main objective - to find a cure for RDEB and announces that the FDA is now allowing the second phase of this clinical trial in which Fibrocell will be enrolling six pediatric patients ages 7 and older.
show less
Information
Author | 90.3 WHPC |
Organization | 90.3 WHPC |
Website | - |
Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company